BARIUM SULFATE - Generic Drug Details
✉ Email this page to a colleague
What are the generic sources for barium sulfate and what is the scope of freedom to operate?
Barium sulfate
is the generic ingredient in thirteen branded drugs marketed by Bracco and is included in three NDAs. Additional information is available in the individual branded drug profile pages.One supplier is listed for this compound.
Summary for BARIUM SULFATE
US Patents: | 0 |
Tradenames: | 13 |
Applicants: | 1 |
NDAs: | 3 |
Finished Product Suppliers / Packagers: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 104 |
Clinical Trials: | 2 |
Patent Applications: | 9 |
What excipients (inactive ingredients) are in BARIUM SULFATE? | BARIUM SULFATE excipients list |
DailyMed Link: | BARIUM SULFATE at DailyMed |
Recent Clinical Trials for BARIUM SULFATE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
University of California, San Francisco | |
General Electric | |
Mayo Clinic | Phase 2/Phase 3 |
Pharmacology for BARIUM SULFATE
Drug Class | Radiographic Contrast Agent |
Mechanism of Action | X-Ray Contrast Activity |
Medical Subject Heading (MeSH) Categories for BARIUM SULFATE
US Patents and Regulatory Information for BARIUM SULFATE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Bracco | ENTERO VU 24% | barium sulfate | SUSPENSION;ORAL | 208143-008 | May 29, 2020 | RX | Yes | Yes | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | ||||
Bracco | VARIBAR THIN HONEY | barium sulfate | SUSPENSION;ORAL | 208143-006 | Jan 23, 2018 | RX | Yes | Yes | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | ||||
Bracco | E-Z-HD | barium sulfate | FOR SUSPENSION;ORAL | 208036-001 | Jan 11, 2016 | RX | Yes | Yes | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | ||||
Bracco | E-Z-PAQUE | barium sulfate | FOR SUSPENSION;ORAL | 208036-002 | Apr 7, 2017 | RX | Yes | Yes | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | ||||
Bracco | VARIBAR NECTAR | barium sulfate | SUSPENSION;ORAL | 208143-004 | Jul 7, 2017 | RX | Yes | Yes | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | ||||
Bracco | TAGITOL V | barium sulfate | SUSPENSION;ORAL | 208143-005 | Aug 4, 2017 | RX | Yes | Yes | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | ||||
Bracco | E-Z-CAT DRY | barium sulfate | FOR SUSPENSION;ORAL | 208036-003 | Jan 3, 2017 | DISCN | Yes | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
BARIUM SULFATE Market Analysis and Financial Projection Experimental
More… ↓
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.